Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue:
Drug safety advice
-
Statins: class effects identified
-
Varenicline: safety update
-
Carisoprodol and meprobamate: risks outweigh benefits
Yellow Card scheme update
-
Reporting by patients and the public
Hot topic
-
Biosimilar products
Stop Press
-
Duphaston/Duphaston HRT (dydrogesterone): withdrawal of Marketing Authorisation
-
Herbal safety news: OSAS (intensive body lotion with aloe vera) found to contain steroids
-
Rosiglitazone: new contraindications and warnings
Other information from the MHRA
-
Patient Information Leaflet of the month
-
Please report suspected counterfeit medicines
-
Midwife prescribing: public consultation
Drug Safety Update: Volume 1, Issue 7, February 2008 
